Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SHORLA

  • FDA Approval
  • Nov. 25, 2024, 15:19 UTC
  • 41

FDA approve IMATINIB

Comment Full text

BRIDGEBIO PHARMA INC

  • FDA Approval
  • Nov. 25, 2024, 13:49 UTC
  • 29

FDA approve ACORAMIDIS

Comment Full text

LEGACY PHARMA USA

  • FDA Approval
  • Nov. 25, 2024, 13:49 UTC
  • 21

FDA approve TIZANIDINE HYDROCHLORIDE

Comment Full text

LEGACY PHARMA USA

  • FDA Approval
  • Nov. 25, 2024, 13:49 UTC
  • 25

FDA approve TIZANIDINE HYDROCHLORIDE

Comment Full text

AOP ORPHAN PHARMACEUTICALS GMBH

  • FDA Approval
  • Nov. 25, 2024, 12:21 UTC
  • 33

FDA approve LANDIOLOL

Comment Full text

SLATE RUN PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 31

FDA approve CINACALCET HYDROCHLORIDE

Comment Full text

UNICHEM

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 27

FDA approve ETODOLAC

Comment Full text

ALEMBIC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30

FDA approve DICLOFENAC SODIUM

Comment Full text

LEADING

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 34

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

SENORES PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 32

FDA approve KETOROLAC TROMETHAMINE

Comment Full text
  • Previous
  • 134
  • 135
  • 136
  • 137
  • 138
  • Next

Search

News categories

  • Technical Exchange News(9391)
  • Event(407)
  • SEC News(153929)
  • FDA Approval(8781)
  • Company Report(721)
  • Business News(104958)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin